Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Herrmann

Showing results (281-290 of 403) with videos related to

Pageof 41
Sort By:
Plos Computational Biology|April 27, 2010
A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variantsBambang S Adiwijaya, Eva Herrmann, Brian Hare, et al.
Plos One|August 26, 2025
Comparison of the ABC/2 formula with computer-assisted volumetry of ischemic cerebellar strokeMilos Arsenovic, Artem Rafaelian, Daniel Dubinski, et al.
Infection|November 12, 2024
Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosisRaja Idris, Alexander Z Dayani, Ana M Groh, et al.
Infectious Diseases and Therapy|September 18, 2014
Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BNancy W Y Leung, Eva Herrmann, George K K Lau, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 11, 2008
Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markersMireen Friedrich-Rust, Constanze Koch, Axel Rentzsch, et al.
Medical Microbiology and Immunology|July 30, 2016
HIV-1 replication in central nervous system increases over time on only protease inhibitor therapyMaximilian Donath, Timo Wolf, Martin Stürmer, et al.
Hepatology (Baltimore, Md.)|May 30, 2003
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trialThomas Berg, Bernd Kronenberger, Holger Hinrichsen, et al.
Antiviral Therapy|June 9, 2006
Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061Eva Herrmann, Stefan Zeuzem, Christoph Sarrazin, et al.
The Journal of Invasive Cardiology|November 23, 2022
TAVI With or Without Predilation: Trends From a Large, Propensity-Score Weighted German Aortic Valve Registry (GARY) PopulationBrunilda Alushi, Alexander Lauten, Umniye Balaban, et al.
Plos One|April 23, 2014
PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis CAntoaneta A Markova, Ulrike Mihm, Verena Schlaphoff, et al.
Pageof 41

Showing results (281-290 of 403) with videos related to

Sort By:
Pageof 41
Plos Computational Biology|April 27, 2010
A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variantsBambang S Adiwijaya, Eva Herrmann, Brian Hare, et al.
Plos One|August 26, 2025
Comparison of the ABC/2 formula with computer-assisted volumetry of ischemic cerebellar strokeMilos Arsenovic, Artem Rafaelian, Daniel Dubinski, et al.
Infection|November 12, 2024
Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosisRaja Idris, Alexander Z Dayani, Ana M Groh, et al.
Infectious Diseases and Therapy|September 18, 2014
Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BNancy W Y Leung, Eva Herrmann, George K K Lau, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 11, 2008
Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markersMireen Friedrich-Rust, Constanze Koch, Axel Rentzsch, et al.
Medical Microbiology and Immunology|July 30, 2016
HIV-1 replication in central nervous system increases over time on only protease inhibitor therapyMaximilian Donath, Timo Wolf, Martin Stürmer, et al.
Hepatology (Baltimore, Md.)|May 30, 2003
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trialThomas Berg, Bernd Kronenberger, Holger Hinrichsen, et al.
Antiviral Therapy|June 9, 2006
Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061Eva Herrmann, Stefan Zeuzem, Christoph Sarrazin, et al.
The Journal of Invasive Cardiology|November 23, 2022
TAVI With or Without Predilation: Trends From a Large, Propensity-Score Weighted German Aortic Valve Registry (GARY) PopulationBrunilda Alushi, Alexander Lauten, Umniye Balaban, et al.
Plos One|April 23, 2014
PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis CAntoaneta A Markova, Ulrike Mihm, Verena Schlaphoff, et al.
Pageof 41